Mother's Promise Women's Probiotic
Mother's Promise Women's Probiotic, NPN 80141133: natural health product licensed in Canada. Medicinal ingredients: Limosilactobacillus Fermentum, Bifidobacterium longum subsp. infantis, Limosilactobacillus reuteri, Lactobacillus delbrueckii subsp. bulgaricus.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Limosilactobacillus Fermentum Source : LF61 | 0.36 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : BI45 | 0.36 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Bifidobacterium longum subsp. Infantis - Whole Cell | 0.36 Milliards d'UFC | Not calculated |
| Limosilactobacillus reuteri Source : LR08 | 0.36 Milliards d'UFC | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : LB42 | 0.18 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius Source : LS97 | 0.36 Milliards d'UFC | Not calculated |
| Lactobacillus helveticus Source : Lactobacillus helveticus - Whole Cell | 0.18 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : LC86 | 0.36 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : HN001 | 0.36 Milliards d'UFC | Not calculated |
| Levilactobacillus Brevis Source : LB01 | 0.36 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Bifidobacterium breve - Cellule entière | 0.36 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : BBr60 | 0.36 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Cellule entière | 0.36 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : BBi32 | 0.36 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : GG | 0.18 Milliards d'UFC | Not calculated |
| Vaccinium macrocarpon Extract : Matériel brut frais Extraction ratio : 50:1 Dry plant equivalent : 7,500 mg | 150 mg | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BLa80 | 1.79 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Inuline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of/Provides antioxidants. Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners. Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones. Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain. Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days.
- Contra-Indications
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
Product record
- Other names
- Women's Probiotic
- Licence holder
- Mother's Promise Inc.
- NPN or DIN-HM
- 80141133
- Status
- Active licence
- Licence date
- 21 May 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80141133
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium macrocarpon
Read the warning, when it applies and the studies cited
CRANBERRY - VACCINIUM MACROCARPON
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
Sources cited by Health Canada (2)
- Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
- Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
Sources cited by Health Canada (4)
- Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
- Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
DRIED CRANBERRY JUICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).
Sources cited by Health Canada (2)
- Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
- Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).
Sources cited by Health Canada (4)
- Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
- Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.
Condition of application: (Recurrent) urinary tract infection.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Mother's Promise Women's Probiotic: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80141133-mother-s-promise-women-s-probiotic, updated 21 May 2025.